Kelly Wiltberger

Kelly currently oversees the Biologics Technical Development Program Leadership function at Biogen, with responsibility for guiding the development strategy and influencing the overall CMC strategy for all protein biologics and gene therapy programs. Over several years in industry, she has held roles across Manufacturing Sciences, Manufacturing, Proteins Pilot Scale Development, Cell Culture Development and CMC Asset Management. Kelly holds a BS in Chemical Engineering from the University of Rochester and an MBA from UNC Chapel Hill.

Appearances

This speaker has made no appearances.